Clinical trial
A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of…
NCT00251485 · Veeda Oncology, Other · Completed
Key facts
| NCT number | NCT00251485 |
|---|---|
| Title | A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer |
| Official title | A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer |
| Lead sponsor | Veeda Oncology, Other |
| Collaborators | Bristol-Myers Squibb Industry Sanofi |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Cetuximab |
| Enrollment | 82 |
| Start date | Mar 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Nov 10, 2005 |
| Last update posted | Aug 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: